Bone Marrow CD8 + Abundance Inversely Correlates with Progressive Marrow Fibrosis and Myelodysplastic Evolution in...

Area of Science:

• Immunology
• Hematology
• Genetics

Background:

• GATA2 deficiency is a rare inborn error of immunity with variable phenotypes, often involving bone marrow (BM) changes like hypocellularity and myelodysplastic syndrome (MDS).
• Hematopoietic stem cell transplantation is the only cure for GATA2 deficiency due to acute myeloid leukemia risk.
• Novel predictors for GATA2 deficiency progression are needed, as current markers like cytogenetic abnormalities and somatic mutations are insufficient.

Purpose of the Study:

• To investigate the role of CD8+ T cells in GATA2 deficiency and their association with myelodysplastic syndrome (MDS) progression.
• To monitor CD8+ T-cell evolution in a GATA2-deficient patient longitudinally.
• To identify potential novel biomarkers for disease progression in GATA2 deficiency.

Main Methods:

• Longitudinal monitoring of peripheral and bone marrow (BM) lymphocyte subsets in a young adult with GATA2 deficiency.
• Focus on the evolution of CD8+ T cells in relation to myelodysplastic syndrome (MDS) progression.
• Clinical and immunological data collection over time.

Main Results:

• The patient presented typical GATA2-deficient immune-hematological features, including monocytopenia and B-/NK-cell deficiency.
• Peripheral CD8+ T-cell levels remained stable, but a significant reduction in BM CD8+ T cells was observed.
• This reduction in BM CD8+ T cells correlated with myelodysplastic syndrome (MDS) progression.

Conclusions:

• A decrease in bone marrow (BM) CD8+ T cells may indicate immune surveillance escape and disease progression in GATA2 deficiency.
• These findings suggest BM CD8+ T cells as a potential early marker for GATA2 deficiency and MDS evolution.
• Further research is warranted to explore the role of BM CD8+ T cells in GATA2 deficiency for improved follow-up and therapeutic strategies.